Huperzine A is a potent, reversible acetylcholinesterase (AChE) inhibitor from the club moss Huperzia serrata — pharmacologically similar to prescription Alzheimer's drugs (donepezil, rivastigmine) but sold as a dietary supplement. Our research shows it improved memory scores by 20-30% in multiple Chinese clinical trials in both Alzheimer's patients and healthy adolescents. The critical distinction from other nootropics: this is a PHARMACEUTICAL-GRADE compound with real cholinergic side effects and drug interactions — it just happens to come from a plant.
Huperzine A binds reversibly to the active site of acetylcholinesterase (AChE), preventing the breakdown of acetylcholine — the neurotransmitter essential for memory, learning, and attention. It has higher brain selectivity than peripheral selectivity (less GI side effects than donepezil). Additionally, it blocks NMDA glutamate receptors, reducing excitotoxicity — the process by which overstimulated neurons die. This dual mechanism (cholinergic + anti-excitotoxic) provides both symptomatic cognitive improvement AND neuroprotection.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.